Calgranulin A (S100A8) Immunostaining : A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)

dc.contributor.author	Stenzl, Arnulf
dc.contributor.author	Hennenlotter, Jörg
dc.date.accessioned	2019-07-16T08:13:33Z
dc.date.available	2019-07-16T08:13:33Z
dc.date.issued	2018
dc.identifier.issn	1865-8652
dc.identifier.uri	http://hdl.handle.net/10900/90571
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s12325-018-0789-7	de_DE
dc.subject.ddc	610	de_DE
dc.title	Calgranulin A (S100A8) Immunostaining : A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_00569
utue.publikation.seiten	2054-2068	de_DE
utue.personen.roh	Nicklas, Andre P.
utue.personen.roh	Kramer, Mario W.
utue.personen.roh	Serth, Jurgen
utue.personen.roh	Hennenlotter, Joerg
utue.personen.roh	Hupe, Marie C.
utue.personen.roh	Reimer, Daniel U.
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Merseburger, Axel S.
utue.personen.roh	Kuczyk, Markus A.
utue.personen.roh	von Klot, Christoph-Alexander J.
dcterms.isPartOf.ZSTitelID	Advances in Therapy	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	35	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE

Files in this item

Files	Size	Format	View
There are no files associated with this item.